Changes of sphingolipids profiles after ischemia-reperfusion injury in the rat liver

Chinese Medical Journal

Volumn 122, Issue 24, 2009, Pages 3025-3031

  Zhai, Shu Ting ^a   Liu, Guang Yi ^b   Xue, Fei ^a   Sun, Gong Ping ^b   Liang, Liang ^a   Chen, Wei ^a   Xu, Guo Dong ^a   Li, Jun Jian ^a   Yang, Jun ^b   Liang, Ting Bo ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Ischemia reperfusion; Lipidomic; Liver; Matrix assisted laser desorption ionization time of flight mass spectrometry; Sphingolipids

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CERAMIDE; SPHINGOLIPID; SPHINGOMYELIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; LIPIDOMICS; LIVER INJURY; LIVER ISCHEMIA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SPHINGOLIPIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74549191961     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.24.022     Document Type: Article

References (29)

1. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006; 43: S31-S44.
2. Kim JS, He L, Qian T, Lemasters JJ. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia/reperfusion injury to hepatocytes. Curr Mol Med 2003; 3: 527-535.
3. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18: 891-902.
4. Schwabe RF, Brenner DA. Mechanisms of liver injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290: G583-G589.
5. Alessenko AV, Galperin EI, Dudnik LB, Korobko VG, Mochalova ES, Platonova LV, et al. Role of tumor necrosis factor alpha and sphingomyelin cycle activation in the induction of apoptosis by ischemia/reperfusion of the liver. Biochemistry (Mosc) 2002; 67: 1347-1355.
6. Lawler JF Jr, Yin M, Diehl AM, Roberts E, Chatterjee S. Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. J Biol Chem 1998; 273: 5053-5059.
7. Smith WL, Merrill AH Jr. Sphingolipid metabolism and signaling minireview series. J Biol Chem 2002; 277: 25841-25842.
8. Yang J, Yu Y, Sun S, Duerksen-Hughes PJ. Ceramide and other sphingolipids in cellular responses. Cell Biochem Biophys 2004; 40: 323-350.
9. Marí M, Fernández-Checa JC. Sphingolipid signalling and liver diseases. Liver Int 2007; 27: 440-450.
10. Morales A, Lee H, Goni FM, Kolesnick R, Fernandez-Checa JC. Sphingolipids and cell death. Apoptosis 2007; 12: 923-939.
11. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat Med 2007; 13: 164-170.
12. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov 2005; 4: 594-610.
13. Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res 2003; 44: 1071-1079.
14. Schiller J, Süss R, Arnhold J, Fuchs B, Lessig J, Müller M, et al. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research. Prog Lipid Res 2004; 43: 449-488.
15. Fujiwaki T, Yamaguchi S, Tasaka M, Takayanagi M, Isobe M, Taketomi T. Evaluation of sphingolipids in vitreous bodies from a patient with Gaucher disease, using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 806: 47-51.
16. Ma X, Liu G, Wang S, Chen Z, Lai M, Liu Z, et al. Evaluation of sphingolipids changes in brain tissues of rats with pentylenetetrazol-induced kindled seizures using MALDI-TOF-MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 859: 170-177.
17. Cho WH, Kim DG, Murase N, Mischinger HJ, Todo S, Starzl TE. Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. Transplantation 1990; 50: 353-355.
18. Huang Y, Yang J, Shen J, Chen FF, Yu Y. Sphingolipids are involved in N-methyl-N'-nitro-N-nitrosoguanidine induced epidermal growth factor receptor clustering. Biochem Biophys Res Commun 2005; 330: 430-438.
19. Llacuna L, Marí M, Garcia-Ruiz C, Fernandez-Checa JC, Morales A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 2006; 44: 561-572.
20. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004; 8: 445-454.
21. Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J Biol Chem 2005; 280: 27879-27887.
22. Kawakami F, Suzuki K, Ohtsuki K. A novel consensus phosphorylation motif in sulfatide- and cholesterol-3-sulfate-binding protein substrates for CK1 in vitro. Biol Pharm Bull 2008; 31: 193-200.
23. Sakamoto H, Okamoto K, Aoki M, Kato H, Katsume A, Ohta A, et al. Host sphingolipid biosynthesis as a target for hepatitis C virus therapy. Nat Chem Biol 2005; 1: 333-337.
24. Solomon JC, Sharma K, Wei LX, Fujita T, Shi YF. A novel role for sphingolipid intermediates in activation-induced cell death in T cells. Cell Death Differ 2003; 10: 193-202.
25. Son JH, Yoo HH, Kim DH. Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HL-60 cells. J Toxicol Environ Health A 2007; 70: 1310-1318.
26. Carini R, Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-1491.
27. Der P, Cui J, Das DK. Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts. J Mol Cell Cardiol 2006; 40: 313-320.
28. Vessey DA, Kelley M, Li L, Huang Y, Zhou HZ, Zhu BQ, et al. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 2006; 12: BR318-324.
29. Gómez-Muñoz A. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim Biophys Acta 2006; 1758: 2049-2056.